DataMeds AI (MEDS): SEC Form 3: New insider Newell A. Jeffrey claimed no ownership of stock in the company
Stocks in this Quantisnow insightHealth Care
Keep researching MEDS
- MEDS insider tradesEvery buy and sale reported by DataMeds AI Inc. officers, directors and large holders.
- What is Form 3?The initial SEC statement of beneficial ownership filed by a company's officers, directors and 10% holders when they first become insiders.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- MEDS financial statementsRevenue, profit, cash flow and balance sheet from DataMeds AI Inc.'s SEC filings.
- MEDS dividend historyDividends DataMeds AI Inc. has declared, with ex-dates and payment dates.
Quantisnow market dataNASDAQ
MEDS
DataMeds AI Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
Get push alerts for MEDS
Full MEDS profile on Quantisnow Follow MEDS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time